How does a VC source a unicorn startup at the early stage?

Ashish Kumar


Partner, The Fundamentum Partnership (growth-focused VC Fund)



Sharing his insights on:


1. As a part of a VC firm, what got you interested in the
healthcare sector?
2. You had assessed several players in the pharma space, what
were the 3 key factors that stood out for PharmEasy?
3. Besides the team, what other factors drove you to commit to
PharmEasy?
4. In general, what makes a team shine over others when it comes
to investment?
5. Coming back to PharmEasy, you tweeted about channel
relationships, margins, and supply chain as key differentiators,
can you elaborate on that?
6. So quite a cliche question, did you ever envisage that
PharmEasy would turn up as a unicorn someday?
7. From the founders' perspective, what should they focus on at
the early stage, to become a leader in any sector?
8. Finally, tell us about "Fundamentum Partnership," and what's
your investment thesis?